Assessment of relative efficacies of 5-HT1A receptor ligands by means of in vivo animal models
- 21 November 1996
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 315 (3) , 245-254
- https://doi.org/10.1016/s0014-2999(96)00621-8
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Behavioral effect of beta-blocking drugs resulting from the stimulation or the blockade of serotonergic 5-HT1B receptorsPharmacology Biochemistry and Behavior, 1994
- Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agentsTrends in Pharmacological Sciences, 1993
- Comparison of acute and repeated treatment with the 5‐HT1A receptor ligands 8‐OH‐DPAT and ipsapirone in animal models of anxiety and depressionDrug Development Research, 1993
- Structural analysis by the comparative molecular field analysis method of the affinity of β-adrenoreceptor blocking agents for 5-HT1A and 5-HT1B receptorsEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl) piperazinePharmacology Biochemistry and Behavior, 1992
- Ethopharmacological studies differentiate the effects of various serotonergic compounds on aggression in ratsDrug Development Research, 1992
- Characterization of the Discriminative Stimulus Properties Induced by 5‐HT1and 5‐HT2Agonists in RatsBasic & Clinical Pharmacology & Toxicology, 1989
- Neurochemical profile in vitro of irindalone: A5-HT2-receptor antagonistDrug Development Research, 1988
- Evidence that ICI 118, 551 is a potent, highly beta2-selective adrenoceptor antagonist and can be used to characterize beta-adrenoceptor populations in tissuesLife Sciences, 1980
- Blockade of 5-hydroxytryptamine receptors in the central nervous system by β-adrenoceptor antagonistsNeuropharmacology, 1977